The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery

Nanoparticulate drug delivery systems offer several advantages over conventional forms of dosing, with polymer nanoparticles prepared from biomaterials being good candidates for use in drug delivery. We selected fluorouracil (5FU) as a model drug because it has been suggested that chitosan might prevent the side effects induced by 5FU. We have exploited the complexation between oppositely charged macromolecules to develop a safe and efficient method of preparation of chitosan bead formulations for use as drug delivery systems. In this study, we examined the effect that the molecular weight of chitosan had on the resulting nanoparticles' properties; the initial concentration of chitosan was held constant, but its molecular weight was decreased through the action of NaNO2. FTIR spectroscopy suggested that no structural change occurred during the depolymerization process. The diameters of the nanoparticles—determined using dynamic light scattering and TEM techniques—decreased as the value of the viscosity of molecular weight (Mv) of chitosan decreased. In addition, we prepared fluorouracil-loaded chitosan nanoparticles and characterized them using NMR spectroscopy. The encapsulation efficiency increased as the value of Mv of chitosan decreased. The particles produced using 55-kDa chitosan had a mean diameter of 70.6 nm and a 66% drug loading.